Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Chiu

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
BMC Family Practice|November 25, 2011
The epidemiology and natural history of depressive disorders in Hong Kong's primary careWeng Yee Chin, Cindy L K Lam, Samuel Y S Wong, et al.
Annals of Internal Medicine|August 5, 2009
Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trialBenjamin J Cowling, Kwok-Hung Chan, Vicky J Fang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancerJ S Chen, C Hsu, N J Chiang, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
BMC Family Practice|November 25, 2011
The epidemiology and natural history of depressive disorders in Hong Kong's primary careWeng Yee Chin, Cindy L K Lam, Samuel Y S Wong, et al.
Annals of Internal Medicine|August 5, 2009
Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trialBenjamin J Cowling, Kwok-Hung Chan, Vicky J Fang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancerJ S Chen, C Hsu, N J Chiang, et al.
Pageof 5